New hope for teens with rare tumors: lutathera safety trial underway
NCT ID NCT04711135
First seen Feb 13, 2026 · Last updated May 15, 2026 · Updated 11 times
Summary
This study tests a radioactive drug called Lutathera in teenagers aged 12 to 18 who have rare tumors of the gut, pancreas, or nerve tissue. The goal is to check how safe the drug is and how much radiation reaches organs like the kidneys and bone marrow. About 11 participants will receive the treatment and be monitored for side effects. This is not a cure, but aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHEOCHROMOCYTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Léon Berard
Lyon, France
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229-3039, United States
-
Hospital Universitari Vall d'Hebron
Barcelona, Spain
-
Maria Sklodowska-Curie National Research Institute of Oncology
Gliwice, Poland
-
University College Hospital of London
London, United Kingdom
-
University of Kentucky
Lexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.